TGTX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

TG Therapeutics Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 52.03 USD
-7.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 34.6% above the Trend Line and sits at 78.6% of its 52-week range. The latest completed week returned -7.2%, after a -2.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers. Options positioning is mixed with 44/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 2d.

Setup score 63 out of 100
Latest Close 52.03 USD 31 Jul 2026
1W Return -7.2% latest completed week
4W Return -2.4% short-term follow-through
12W Return 21.4% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 13-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 10 reversal markers appear in the recent smart-money tape.
  • The latest week was a sharp negative move.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.2% Latest completed week; four-week move -2.4%. Indicator stack 59/71 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.81% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 44/100 conviction; expected move 14.7%. News sentiment 56/100 61 relevant articles in the latest sentiment read. Event risk 2d Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 34.6% above the Trend Line and sits at 78.6% of its 52-week range. The latest completed week returned -7.2%, after a -2.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9612-week average 0.83

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.96Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1010 reversal markers

No recent accumulation markers. 10 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.4% over four weeks, 21.4% over 12 weeks, and 48.6% over one year. The current trend has remained active for 13 consecutive weeks.

Performance by holding period

1W-7.2%
4W-2.4%
12W21.4%
26W76.8%
52W48.6%
Active trend streak13 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.30Latest activity-pressure read.
Pressure change-30.9%Four-week change in activity pressure.
Leadership34.68Latest relative-leadership reading.
RS change-2.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength30/100Blend of value, momentum, and quality. Underlying universe rank 71; rank 1 is best.
Value5/100Relative valuation strength. Underlying universe rank 96; rank 1 is best.
Quality68/100Profitability and accounting quality. Underlying universe rank 33; rank 1 is best.
Momentum86/100Medium-term price momentum. Underlying universe rank 15; rank 1 is best.
Growth88/100Revenue and earnings growth. Underlying universe rank 13; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework17/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.6x
Price divided by trailing earnings.
Price / sales
12.2x
Market value relative to trailing revenue.
EV / EBITDA
59.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-0.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
83.0%
Gross profit retained from each unit of revenue.
Operating margin
21.4%
Operating profit retained from revenue.
Free-cash-flow margin
-2.0%
Free cash flow generated from revenue.
Return on invested capital
12.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
81.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
2.1%
Net share repurchases relative to market value.
Shareholder yield
2.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

TGTX shows mixed options pressure with a 44/100 conviction score, put-call volume ratio of 1.00, expected move of 14.7%, and Sharemaestro trend signal active.

Conviction44/100
Expected move14.7%
Put/call volume1.00
Pressure6
Speculation30
Volatility89
Trend agreement100
Open options detail
Insider activity5 / 0

5 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 61 relevant articles.

25 positive · 31 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings2dNext report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
Options expected move14.7%Nearest-chain priced movement where available.
52-week drawdown-12.3%Distance below the 52-week high.
13-week volatility10.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher15 of 2611 weeks finished lower.
Best week+26.6%Week of 8 May.
Worst week-7.8%Week of 15 May.
Latest week-7.2%Week of 31 Jul.

Shape of recent returns

Strong gains10
Modest gains5
Flat weeks0
Modest losses6
Sharp losses5
Recent vol10.3%13-week weekly-return volatility.
Base vol7.6%52-week weekly-return volatility.
Up/down split28/24Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -4.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape64/100

Trend, activity pressure, participation, and risk combine to a 64/100 tape read.

 Indicator analysis79/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 10/12.

Activity pressure 0.96; 10 reversal markers Next-Week ExpectancyPositive 55.81%

Next-week expectancy is positive with a 55.81% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors45/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 22; Small Cap Core rank 92 SVQF17/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 602.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options63/100

TGTX shows mixed options pressure with a 44/100 conviction score, put-call volume ratio of 1.00, expected move of 14.7%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 14.7% Sentiment56/100

Weighted news tone is neutral across 61 relevant articles.

TG Therapeutics, Inc. Revenue Breakdown – MIL:1TGTX Insiders5 / 0

5 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings2d

Next report is scheduled for 03 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202652.03 USD-7.2%38.67 USD27.40 USD1.3034.6812.3MOn
24 Jul 202656.04 USD2.1%37.91 USD27.14 USD1.4846.468.3MOn
17 Jul 202654.87 USD-3.9%37.07 USD26.91 USD1.6741.9211.2MOn
10 Jul 202657.12 USD7.1%36.27 USD26.69 USD1.8142.149.4MOn
3 Jul 202653.31 USD-4.5%35.41 USD26.46 USD1.8935.619.8MOn
26 Jun 202655.83 USD4.9%34.66 USD26.28 USD1.7943.6719.3MOn
19 Jun 202653.22 USD7.5%33.91 USD26.08 USD1.4731.3315.4MOn
12 Jun 202649.52 USD23.3%33.20 USD25.89 USD1.2225.6114.3MOn
5 Jun 202640.16 USD5.9%32.58 USD25.74 USD1.104.2211.0MOn
29 May 202637.94 USD-2.4%32.32 USD25.66 USD1.26-6.595.1MOn
22 May 202638.87 USD-1.6%32.21 USD25.58 USD1.29-2.106.9MOn
15 May 202639.50 USD-7.8%32.03 USD25.51 USD1.430.2110.3MOn
8 May 202642.86 USD26.6%31.87 USD25.45 USD1.437.9919.0MOn
1 May 202633.85 USD-7.6%31.56 USD25.37 USD1.28-10.298.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.